Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell Lines

被引:42
作者
Norgaard, P
SpangThomsen, M
Poulsen, HS
机构
[1] RIGSHOSP,FINSEN CTR,RADIAT BIOL SECT,DK-2100 COPENHAGEN,DENMARK
[2] UNIV COPENHAGEN,INST PATHOL ANAT,DK-2100 COPENHAGEN,DENMARK
关键词
small-cell lung cancer; cell line; transforming growth factor beta receptor; transforming growth factor beta receptor mRNA; autoregulation;
D O I
10.1038/bjc.1996.201
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In small-cell lung cancer cell lines resistance to, (TGF)-beta(1), was previously shown to correlate with lack of TGF-beta receptor I (RT) and II (RII) proteins. To further investigate the role of these receptors, the expression of mRNA for RI, RII and beta-glycan (RIII) was examined. The results showed that loss of RII mRNA, correlated with TGF-beta(1) resistance. In contrast, RI- and beta-glycan mRNA was expressed by all cell lines, including those lacking expression of these proteins. According to Southern blot analysis, the loss of type II mRNA was not due to gross structural changes in the gene. The effect of TGF-beta(1) on expression of TGF-beta receptor mRNA (receptor autoregulation) was examined by quantitative Northern blotting in four cell lines with different expression of TGF-beta receptor proteins. In two cell lines expressing all three TGF-beta receptor proteins beta-glycan mRNA was rapidly down regulated and this effect was sustained throughout the 24 h observation period. RI and RII mRNAs were slightly increased 24 h after treatment. In one cell line sensitive to growth inhibition by TGF-beta(1), but lacking beta-glycan expression, and one cell line expressing only beta-glycan and thus TGF-beta(1)-resistant, no autoregulation of mRNA of either TGF-beta receptor was demonstrated. The results suggest that TGF-beta(1) regulates the expression of its receptors, in particular beta-glycan, and that tills effect is dependent on co-expression of beta-glycan, RI and RII.
引用
收藏
页码:1037 / 1043
页数:7
相关论文
共 47 条
[1]   GROWTH-FACTORS AND CANCER [J].
AARONSON, SA .
SCIENCE, 1991, 254 (5035) :1146-1153
[2]  
ASSOIAN RK, 1984, CELL, V36, P35, DOI 10.1016/0092-8674(84)90071-0
[3]   TGF-BETA RECEPTORS AND ACTIONS [J].
ATTISANO, L ;
WRANA, JL ;
LOPEZCASILLAS, F ;
MASSAGUE, J .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1994, 1222 (01) :71-80
[4]   IDENTIFICATION OF HUMAN ACTIVIN AND TGF-BETA TYPE-I RECEPTORS THAT FORM HETEROMERIC KINASE COMPLEXES WITH TYPE-II RECEPTORS [J].
ATTISANO, L ;
CARCAMO, J ;
VENTURA, F ;
WEIS, FMB ;
MASSAGUE, J ;
WRANA, JL .
CELL, 1993, 75 (04) :671-680
[5]  
BERENDSEN HH, 1988, CANCER RES, V48, P6891
[6]  
BOYD FT, 1989, J BIOL CHEM, V264, P2272
[7]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[8]   EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) RECEPTORS AND EXPRESSION OF TGF-BETA-1, TGF-BETA-2 AND TGF-BETA-3 IN HUMAN SMALL-CELL LUNG-CANCER CELL-LINES [J].
DAMSTRUP, L ;
RYGAARD, K ;
SPANGTHOMSEN, M ;
POULSEN, HS .
BRITISH JOURNAL OF CANCER, 1993, 67 (05) :1015-1021
[9]  
DELEIJ L, 1985, CANCER RES, V45, P6024
[10]   DETERMINATION OF TYPE-I RECEPTOR SPECIFICITY BY THE TYPE-II RECEPTORS FOR TGF-BETA OR ACTIVIN [J].
EBNER, R ;
CHEN, RH ;
LAWLER, S ;
ZIONCHECK, T ;
DERYNCK, R .
SCIENCE, 1993, 262 (5135) :900-902